Beta-Blocker Selection and Starting Dose
For heart failure with reduced ejection fraction (HFrEF), start with bisoprolol 1.25 mg once daily, carvedilol 3.125 mg twice daily, or metoprolol succinate CR/XL 12.5-25 mg once daily—these are the only three beta-blockers proven to reduce mortality in heart failure. 1, 2, 3, 4
Which Beta-Blocker to Choose
Only three beta-blockers have demonstrated mortality reduction in heart failure trials and should be used 3:
- Bisoprolol (β1-selective)
- Carvedilol (non-selective with α-blocking and vasodilatory properties)
- Metoprolol succinate CR/XL (β1-selective, extended-release formulation)
Critical caveat: Metoprolol tartrate (immediate-release) should NOT be used—only the succinate CR/XL formulation has proven benefits 2. The benefits of beta-blockers cannot be assumed to be a class effect 3.
Starting Doses (Evidence-Based)
| Beta-Blocker | Starting Dose | Target Dose | Titration Interval |
|---|---|---|---|
| Bisoprolol | 1.25 mg once daily | 10 mg once daily | Every 1-2 weeks [1,4] |
| Carvedilol | 3.125 mg twice daily | 25-50 mg twice daily* | Every 2 weeks [1,4] |
| Metoprolol CR/XL | 12.5-25 mg once daily | 200 mg once daily | Every 2 weeks [1,4] |
*50 mg twice daily for patients >85 kg 3
Clinical Context Determines Approach
For Stable Heart Failure (Outpatient)
- Patient must be on background ACE inhibitor therapy (unless contraindicated) 1
- Patient should be relatively stable without IV inotropes or marked fluid overload 1
- Start with the low doses above and double every 1-2 weeks if tolerated 2, 4, 2
- Target the doses proven effective in trials, but remember: some beta-blocker is better than no beta-blocker 2, 3, 2
For Acute Coronary Syndrome/Unstable Angina
If using IV beta-blockers for acute management 5, 6, 7:
- Metoprolol: 5 mg IV over 1-2 minutes, repeat every 5 minutes up to 15 mg total, then transition to oral 25-50 mg every 6 hours
- Esmolol: 500 mcg/kg loading dose over 1 minute, then 50 mcg/kg/min infusion (short-acting, useful if concerns about tolerance)
- Atenolol: 5 mg IV over 5 minutes, repeat once after 10 minutes if needed
For Low Blood Pressure Patients
If patient has HFrEF with low BP but is asymptomatic or mildly symptomatic 8:
- Start SGLT2 inhibitors and mineralocorticoid receptor antagonists first (least BP effect)
- Then add low-dose selective β1-blocker (bisoprolol or metoprolol) as these have less BP-lowering effect than carvedilol
- Consider ivabradine as alternative if beta-blockers not tolerated hemodynamically 8
Absolute Contraindications
Do NOT start beta-blockers if 4, 2:
- Asthma (COPD is NOT a contraindication)
- Second- or third-degree heart block without permanent pacemaker
- Sick sinus syndrome without pacemaker
- Sinus bradycardia <50 bpm
Monitoring During Titration
Check at each dose increase 1, 2:
- Heart rate (target 50-60 bpm at rest)
- Blood pressure
- Signs of congestion (weight, edema, JVP)
- Symptoms (fatigue, dyspnea)
Problem-solving during titration 2:
- Worsening congestion: Increase diuretics first; only halve beta-blocker dose if diuretics don't work
- Symptomatic bradycardia (<50 bpm): Halve dose or temporarily stop; review other rate-slowing drugs
- Asymptomatic hypotension: No action needed
- Symptomatic hypotension: Reduce other vasodilators first, not the beta-blocker
Common Pitfalls to Avoid
- Using wrong metoprolol formulation: Only metoprolol succinate CR/XL is proven effective, not tartrate 2
- Stopping abruptly: Risk of rebound ischemia and arrhythmias—taper if discontinuation necessary 2
- Undertitration: Real-world data shows only 15-18% of patients reach target doses 9, 10, yet higher doses provide greater benefit
- Avoiding in COPD: COPD is not a contraindication; use β1-selective agents cautiously 4, 2
- Stopping during hospitalization: In patients admitted with worsening HF, reduce dose if needed but restart/uptitrate before discharge 2, 4